Hokko Chemical Industry (4992) Q3 2025 earnings summary

Executive summary

• Revenue for the nine months ended August 31, 2025, increased by 5.9% year-over-year to ¥41,578 million, driven by strong growth in the agrochemical segment.

• Operating income rose 8.5% year-over-year to ¥4,846 million, and net income attributable to shareholders increased 11.3% to ¥4,127 million, aided by gains from the sale of investment securities.

• Comprehensive income surged 141.5% year-over-year to ¥8,297 million.

Financial highlights

• Gross profit for the period was ¥10,536 million, up from ¥10,024 million year-over-year.

• Ordinary income increased 6.3% year-over-year to ¥5,580 million, despite foreign exchange losses.

• EPS for the period was ¥156.81, up from ¥136.91 in the prior year.

• Total assets at quarter-end were ¥77,205 million, up ¥11,883 million from the previous year-end.

• Net assets increased to ¥52,712 million, with an equity ratio of 68.3%.

Outlook and guidance

• Full-year revenue is forecast at ¥47,500 million, up 2.8% year-over-year, with operating income of ¥4,750 million (+4.6%) and net income of ¥3,850 million (down 3.9%).

• No changes have been made to the previously announced earnings forecast.

• Year-end dividend forecast revised to ¥26.00 per share, including a ¥6.00 commemorative dividend, for a total annual dividend of ¥46.00.